These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice. Jo Y, Hamilton JS, Hwang S, Garland K, Smith GA, Su S, Fuentes I, Neelam S, Thompson BM, McDonald JG, DeBose-Boyd RA. Elife; 2019 Feb 20; 8():. PubMed ID: 30785396 [Abstract] [Full Text] [Related]
8. The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase. Schumacher MM, Elsabrouty R, Seemann J, Jo Y, DeBose-Boyd RA. Elife; 2015 Mar 05; 4():. PubMed ID: 25742604 [Abstract] [Full Text] [Related]
16. Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation. Chen X, Furukawa N, Jin DY, Liu Y, Stafford DW, Williams CM, Suhara Y, Tie JK. FEBS J; 2022 May 05; 289(9):2613-2627. PubMed ID: 34813684 [Abstract] [Full Text] [Related]
17. Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1. Elsabrouty R, Jo Y, Hwang S, Jun DJ, DeBose-Boyd RA. Elife; 2021 Nov 29; 10():. PubMed ID: 34842525 [Abstract] [Full Text] [Related]